315 related articles for article (PubMed ID: 23255589)
21. Vγ1
Wan F; Yan K; Xu D; Qian Q; Liu H; Li M; Xu W
Mol Immunol; 2017 Jan; 81():16-25. PubMed ID: 27886550
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
23. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
24. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
25. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
[TBL] [Abstract][Full Text] [Related]
26. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
27. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
Qian Q; Xiong S; Xu W
Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
[TBL] [Abstract][Full Text] [Related]
28. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
29. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
30. CARD9 mediates T cell inflammatory response in Coxsackievirus B3-induced acute myocarditis.
Sun C; Zhang X; Yu Y; Li Z; Xie Y
Cardiovasc Pathol; 2020; 49():107261. PubMed ID: 32771878
[TBL] [Abstract][Full Text] [Related]
31. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
32. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
33. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication.
Fairweather D; Yusung S; Frisancho S; Barrett M; Gatewood S; Steele R; Rose NR
J Immunol; 2003 May; 170(9):4731-7. PubMed ID: 12707353
[TBL] [Abstract][Full Text] [Related]
34. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
35. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
37. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection.
Richer MJ; Lavallée DJ; Shanina I; Horwitz MS
PLoS One; 2009; 4(1):e4127. PubMed ID: 19122812
[TBL] [Abstract][Full Text] [Related]
39. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
40. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.
Weinzierl AO; Szalay G; Wolburg H; Sauter M; Rammensee HG; Kandolf R; Stevanović S; Klingel K
J Virol; 2008 Aug; 82(16):8149-60. PubMed ID: 18550677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
